| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 1290-IL-010/CF | |||
| Carrier Free | 1290-IL-500/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1619-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1716-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77257-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB17161-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1887-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76697-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1619-SP | |||
![N/A IL-23A/IL-23 P19 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL23_D2300_ELISA_545.jpg "N/A IL-23A/IL-23 P19 [HRP]")
![N/A IL-23A/IL-23 P19 [HRP]](http://images.novusbio.com/fullsize/elisa/IL-23_D2300_ELISA_376.jpg)
![N/A IL-23A/IL-23 P19 [HRP]](http://images.novusbio.com/fullsize/elisa/DATA_IL23_M2300_ELISA_929.jpg "N/A IL-23A/IL-23 P19 [HRP]")
![N/A IL-23A/IL-23 P19 [HRP]](http://images.novusbio.com/fullsize/elisa/IL-23_M2300_ELISA_232.jpg)
![N/A IL-23A/IL-23 P19 [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_IL23_DY1887_ELISA_2375.jpg "N/A IL-23A/IL-23 P19 [Biotin]")
![N/A IL-23A/IL-23 P19 [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_IL23_DY1290_ELISA_2299.jpg "N/A IL-23A/IL-23 P19 [Biotin]")
![Immunohistochemistry-Paraffin: IL-23A/IL-23 P19 Antibody [NBP1-77257] - Abdominal Aortic Aneurysm (AAA) Tissues (Validation of IL-23 in Human Abdominal Aortic Aneurysm (AAA) Tissues](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Immunohistochemistry-Paraffin-NBP1-77257-img0011.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-77257] - Western blot analysis of IL-23 in Raji lysate with IL-23 antibody at 1 ug/ml in the (A) absence and (B) presence of blocking peptide.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-77257-img0003.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-77257] - Loading: 30 ng of human IL-23 recombinant protein.Antibodies: IL-23 (4 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-77257-img0009.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-77257] - Loading: 20ug of lysates per lane.Antibodies: IL-23, (2 ug/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-77257-img0010.jpg)
![Immunohistochemistry: IL-23A/IL-23 P19 Antibody [NBP1-77257] - Staining of human pancreas tissue with antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Immunohistochemistry-NBP1-77257-img0005.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-77257] - Increased cytokine expression in N-WASP-null skin. a qRT-PCR analysis of indicated genes from back skin RNA of con & ko at indicated ages (n > = 3/3, two-tailed unpaired t-test). All normalized to GAPDH. b Representative toluidine blue staining for barrier defect in con & ko mice at indicated ages (P: E15.5 embryos used as positive controls; 2 days (2d) n: 6/5, 6 days(6d) n: 4/5, 3 independent experiments). c Representative immunofluorescence staining & quantification of IL-23p19 of con & ko back skin at indicated ages (n: 3/3, two-tailed paired t-test). Scale bar: 100 µm. d Representative sorting strategy of CD45+, alpha 6H, & alpha 6L cells from con & ko epidermal cells & qRT-PCR analysis of IL-23A & IL-17A expression in sorted cells (n: 3/3, mean ± SD, two-tailed unpaired t-test, 3 independent sortings). e Representative immunoblots & quantification of indicated proteins from epidermal lysates of 7–8-week old con & ko mice (n: 4/4, mean ± SD, two-tailed unpaired t-test). f Representative immunoblots & quantification of indicated proteins of co-precipitations of IL-23p19 with IL-12p40 from epidermal lysates of 7–8-week-old con & ko mice (n: 4/4, mean ± SD, two-tailed unpaired t-test; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001) Image collected & cropped by CiteAb from the following publication (//www.nature.com/articles/s41467-018-03704-z), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-77257_rabbit-polyclonal-il-23a-il-23-p19-antibody-31020241616094.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-77257] - Validation of IL-23A/IL-23 P19 in Raji Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed Raji Cells labeling IL-23A/IL-23 P19 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-77257_rabbit-polyclonal-il-23a-il-23-p19-antibody-271120241923687.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-77257] - Validation of IL-23A/IL-23 P19 in Raji Cells. Immunocytochemical analysis of Raji cells using anti-IL-23A/IL-23 P19 antibody at 10 ug/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-77257_rabbit-polyclonal-il-23a-il-23-p19-antibody-2711202419562127.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-77257] - Validation of IL-23A/IL-23 P19 in Human Pancreas Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human pancreas tissue labeling IL-23A/IL-23 P19 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-77257_rabbit-polyclonal-il-23a-il-23-p19-antibody-2711202419392713.gif)
![Western Blot: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-77257] - Validation in Human Raji Cells. Loading: 15 ug of lysates per lane.Antibodies: IL-23A/IL-23 P19 (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane A: Absence of blocking peptideLane B: Presence of blocking peptide.](http://images.novusbio.com/fullsize/nbp1-77257_rabbit-polyclonal-il-23a-il-23-p19-antibody-2711202419381757.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation in Mouse Tissue Lysate. Loading: 15 ug of lysates per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0006.jpg "Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation in Mouse Tissue Lysate. Loading: 15 ug of lysates per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunohistochemistry-Paraffin: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Mouse pancreas tissue with IL23 P19 antibody at 2 ug/ml.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Immunohistochemistry-Paraffin-NBP1-76697-img0002.jpg)
![Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Mouse pancreas tissue lysate with IL-23 P19antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0003.jpg)
![<b>Expression of Tagged Proteins Validation. </b>Western Blot: IL-23A/IL-23 P19 Antibody [NBP1-76697] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human IL-23 recombinant protein per lane. Antibodies: IL-23A/IL-23 P19 NBP1-76697 (1: 0.25 ug/mL, 2: 0.5 ug/mL, 3: 1 ug/mL and 4: 2ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-23A-IL-23-P19-Antibody-Western-Blot-NBP1-76697-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-23A/IL-23 P19 Antibody - BSA Free [NBP1-76697] - Validation of IL-23A/IL-23 P19 in Mouse Pancreas Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse pancreas tissue labeling IL-23A/IL-23 P19 with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (red).](http://images.novusbio.com/fullsize/nbp1-76697_rabbit-polyclonal-il-23a-il-23-p19-antibody-271120241954152.jpg)